People in the News

Feb 02, 2015

Carrie Wolinetz

The National Institutes of Health has appointed Carrie Wolinetz associate director for science policy, effective Feb. 23. Wolinetz currently serves as president of United for Medical Research, a group that advocates for research funding. She also has been serving as deputy vice president for federal relations with the Association of American Universities. She is an adjunct assistant professor at Georgetown University in the School of Foreign Service's program on Science, Technology & International Affairs, and is a past chair of the advocacy committee for the Association for Women in Science. Wolinetz also previously served as director of scientific affairs and public relations at the Federation of American Societies for Experimental Biology.

Feb 02, 2015

Gerald Möller

Gerald Möller has informed Illumina that he will retire from its board of directors, effective immediately before the firm's 2015 annual meeting of stockholders. He has been a director at Illumina since July 2010 and is currently an advisor at HBM Bio Ventures, a Swiss investment firm focusing on biotechnology, emerging pharma, and medical technology. 

Feb 02, 2015

Thomas Bachmann

Bruker BioSpin Group President Thomas Bachmann is resigning from Bruker, effective in July in order to become the president and CEO of the Eppendorf Group. He will remain president of Bruker BioSpin until the end of the second quarter and start his new position no later than Aug. 1, Bruker said in a document filed with the US Securities and Exchange Commission. Bruker will begin a search for his successor. Bachmann has been president of Bruker BioSpin since August 2013 and a member of Eppendorf's supervisory board since 2013.  

Jan 30, 2015

Stephen Fodor, Jami Nachtsheim

Affymetrix Founder and Chairman Stephen Fodor is retiring from the company's board, effective Jan. 30. Jami Nachtsheim will succeed Fodor as Chairwoman. 

Fodor founded Affy in 1992 and initially was the company's scientific director. In 1993, he was named the firm's president and served as its CEO from 1997 to 2008. He has been on the board since Affy's founding and became its chairman in 1999. 

Nachtsheim has been an Affy director since 2010. Three years later, she became its lead independent director.

Jan 29, 2015

Norma Nowak

Norma Nowak has been named the executive director of the University at Buffalo’s Center of Excellence in Bioinformatics and Life Sciences. In addition to her role at the center, Nowak is a professor of biochemistry at UB, as well as the founder and CSO of Empire Genomics , a molecular diagnostics company focused on personalized medicine. In the past, she served as director of the Genomics Shared Resource, a collaborative research lab shared by the UB School of Medicine and Biomedical Sciences and Roswell Park Cancer Institute.

Jan 29, 2015

Tom Oldfield

Dotmatics has hired Tom Oldfield to be a principal software architect on its solutions development team. In the position, he'll be involved in the continuous expansion of Dotmatics' informatics solutions portfolio. 

Oldfield joins the company from the European Bioinformatics Institute (EMBL-EBI) where he was the head of databases and services for the Protein Databank in Europe. He also worked preciously for Accelrys, now Biovia, a Dassault Systèmes company, where he was responsible for developing software solutions for crystallography, sequence/structure alignment for proteins, and sequence alignment/information theory for genomic data.

Jan 29, 2015

Roger Moody, Ann Wallin, Sheli Rosenberg

Nanosphere announced that CFO Roger Moody notified the firm this week that he will step down from his position with the firm on Feb. 11. Nanosphere has appointed Ann Wallin, currently VP of finance and accounting, to serve as interim CFO and chief accounting officer after Moody leaves the firm. In addition, Sheli Rosenberg has resigned as chair of Nanosphere's board of directors. The company said that it will conduct search for a successor chair.

Jan 26, 2015

Frances Heller

Frances Heller has joined Diagnostics For All's board, effective immediately. She currently is a trustee of the Dana-Farber Cancer Institute and a board member at Zafgen and Affinivax. Heller most recently was senior vice president of business development at Bristol-Myers Squibb and was a trustee of the Bristol-Myers Squibb Foundation. Before joining Bristol-Myers Squibb, she was executive vice president of business development at Exelixis Pharmaceuticals.

Jan 23, 2015

John Fazio

John Fazio has informed Sequenom that he won't stand for re-election to the firm's board of directors at its next annual meeting. Fazio has been a board member since 2007. He is a former senior general practice partner of PricewaterhouseCoopers.

Jan 22, 2015

Noah Nasser

AltheaDx appointed Noah Nasser as senior vice president of sales, effective Feb. 2. He will report to AltheaDx CEO Greg Hamilton. Nasser was the global sales leader for Verinata Health, and before that, he was the business unit manager for molecular diagnostics at Quidel. He previously also was GM of the Specialty Products Group at Quidel.

Jan 22, 2015

Michelle Munson

GenoSpace has appointed Aspera CEO Michelle Munson to its board as an independent director. Munson founded Aspera in 2004. IBM acquired the data transfer technology firm in January 2014. Prior to Aspera, she was a software engineer at research and start-up firms specializing in content networking and distributed systems. 

Jan 22, 2015

Johnathan Lancaster

Johnathan Lancaster has joined Myriad Genetics as the vice president of Medical Affairs for Oncology, effective Feb. 9. He will provide medical and scientific leadership across the company's portfolio of molecular and companion diagnostic products and services for oncology. Lancaster will report to Lloyd Sanders, GM for the oncology business unit at Myriad Genetic Laboratories. 

Lancaster has spent the past 12 years at Moffitt Cancer Center, where he's held several posts, including president of Moffitt Medical Group, deputy physician-in-chief and director of the Center for Women's Oncology, and chair of the department of women's oncology. Prior to Moffitt, he was medical director of the Gynecology Dysplasia Clinic at Duke University Medical Center.

Jan 21, 2015

Scott Bortner

RainDance Technologies appointed Scott Bortner its vice president of intellectual property. He will be responsible for strengthening and defending the IP portfolio underlying RainDance's core digital droplet technology and applications for non-invasive, liquid biopsy research. Bortner has more than 25 years of experience in the genomics IP space and has held senior IP counsel positions at Applied Biosystems, Affymetrix, and Natera.

Jan 20, 2015

François Roy, Suzanne Vinet, Brian White-Guay

Génome Québec appointed François Roy, Suzanne Vinet, and Brian White-Guay to its board of directors. Roy has extensive experience as a corporate director and executive in the public and private sectors. He was with the Société générale de financement du Québec and then served as CFO for Québecor. 

Vinet was deputy minister at Agriculture and Agri-Food Canada. Previously, she was president at Canada Economic Development for Québec Regions and associate deputy minister at Health Canada. 

White-Guay has been a member of AmorChem's investment committee since 2011 and joined the faculty of pharmacy at Université de Montréal as a professor in 2008. Prior to that, he was a vice president at Merck, responsible for all clinical operations and medical departments worldwide. He previously was vice president of regulatory affairs for Europe for Merck.

Jan 20, 2015

Gavin Nichols

Certara has tapped Gavin Nichols to serve in the newly created position of president of technology. Nichols will also head Cetara's software business unit. He'll be based in the company's Cary, NC office. In his new roles, Nichols will lead Certara's research and development, product management, and IT teams. He'll also be responsible for developing and positioning the company's biosimulation applications and informatics platforms. 

Nichols joins Certara from Quintiles, where he served as vice president of strategy/enterprise architecture/R&D innovation IT. Before that, he worked for Unisys, Collaborex, and Cap Gemini, holding positions ranging from life science practice head to EMEA general manager.

Jan 20, 2015

Thomas Lynch

DNAStar has hired Thomas Lynch to be its vice president of sales.

Lynch worked for the company previously as a member of its technical sales scientists team. He left DNAsStar in 2011 to work for Aldevron. There, he led sales and business development, most recently serving as director of client relations. Now back at DNAstar, he'll lead the compamy's global sales team.

Jan 20, 2015

Karen Warner

CombiMatrix announced that it has hired Karen Warner to serve as its VP of payer access and reimbursement. She has joined CombiMatrix from Bako Integrated Physician Solutions, where she was director of payer relations. Prior to Bako, she was president of Touch Point Consulting, a payer relations consulting company focused on molecular diagnostics, genetics, and personalized medicine. Warner also previously worked in payer relations and reimbursement at Genoptix Medical Laboratories, Alkermes, and Sanofi-Synthelabo.

Jan 16, 2015

Gary Palmer

Gary Palmer has joined NantHealth in the newly created position of chief medical officer. Palmer was previously senior vice president, medical affairs at Foundation Medicine. Prior to that, he was CMO of On-Q-ity and has held leadership positions at Genomic Health, Kosan Biosciences, Salmedix, and Amgen.

Jan 15, 2015

Atul Butte

The University of California, San Francisco has selected Atul Butte to lead its Institute for Computational Health Sciences, effective April 1. In addition to his role at UCSF, Butte also has been named executive director of clinical informatics for UC Health Sciences and Services. In this position, he will join in the ongoing development and implementation of a UC-wide data warehouse and analytic platform.

Butte is currently chief of Stanford University's Division of Systems Medicine and an associate professor of pediatrics at Stanford and Lucile Packard Children’s Hospital. Previously, he worked as a software engineer at Apple and Microsoft. He trained in computer science and medicine at Brown University and obtained his PhD in health sciences and technology from Harvard Medical School and the Massachusetts Institute of Technology. He has also founded several Bay Area biotech startup companies.

Jan 13, 2015

Nick Ecos

Nick Ecos has been appointed CEO of Biomatrica. Most recently Ecos served as vice president and general manager of licensing and commercial partnering at Thermo Fisher Scientific. He has 20 years of experience in the biotechnology and healthcare business, including positions at Life Technologies and Invitrogen.

Jan 13, 2015

Patrick Carpenter

Vermillion said today that it has appointed Patrick Carpenter general manager of its CLIA laboratory business, Aspira Labs. Carpenter was previously vice president of operations at Miraca Life Sciences. Before that, he held positions at companies including Dianon Systems, VCA/Antech Diagnostics, and Quest Diagnostics.

Jan 12, 2015

Laura Miller

Vermillion said today that it has appointed Laura Miller senior vice president of sales/customer experience. Miller was previously an independent healthcare consultant. Before that, she was president, laboratory services, for HealthTronics Laboratory. She has also held senior leadership roles at PLUS Diagnostics, Dianon Systems, US Labs, and Ventana Medical Systems.

Jan 12, 2015

Merilee Raines

Merilee Raines has joined Affymetrix's board of directors and will serve as a member of the audit committee. Raines served as CFO of Idexx Laboratories from 2003 until her retirement in 2013. Prior to this, she held various management positions at Idexx, including vice president of finance, treasurer, director of finance, and controller.

Jan 09, 2015

Marylyn Ritchie

Marylyn Ritchie has been appointed senior investigator and founding director of Geisinger's newly established Biomedical and Translational Informatics program. Ritchie will maintain her laboratory at Pennsylvania State University where she is also a professor in the department of biochemistry and molecular biology. She is also the director of the school's Center for Systems Genomics. 

As part of her duties at Geisinger, she will recruit faculty members with expertise in health informatics and bioinformatics for the new program 

Jan 09, 2015

Jennifer Skeen, Sue Beruti

BioTheranostics announced Jennifer Skeen has joined the firm as VP of clinical operations, while Sue Beruti joined the company as medical director. 

Skeen has 10 years of clinical laboratory operations management experience and was previously at Pathway Genomics, Asuragen, and Alvern Clinical Laboratories. Beruti was most recently director of pathology and medical affairs at Genoptix, where she headed the Biopharma Medical Division and medical affairs group. 

Pages

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.